XXII 22nd Century Group, Inc. Stock Quote

XXII [AMEX]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.14	Insider Own	2.30%	Shs Outstand	144.26M	Perf Week	3.48%
Market Cap	657.89M	Forward P/E	-	EPS next Y	-0.12	Insider Trans	3.67%	Shs Float	136.27M	Perf Month	23.55%
Income	-19.70M	PEG	-	EPS next Q	-0.03	Inst Own	25.80%	Short Float	5.77%	Perf Quarter	43.87%
Sales	28.10M	P/S	23.41	EPS this Y	32.70%	Inst Trans	19.23%	Short Ratio	1.58	Perf Half Y	416.86%
Book/sh	0.36	P/B	12.39	EPS next Y	0.00%	ROA	-	Target Price	7.00	Perf Year	439.89%
Cash/sh	0.21	P/C	21.22	EPS next 5Y	-	ROE	-	52W Range	0.55 - 6.07	Perf YTD	102.73%
Dividend	-	P/FCF	-	EPS past 5Y	2.60%	ROI	-47.00%	52W High	-28.34%	Beta	1.85
Dividend %	-	Quick Ratio	4.90	Sales past 5Y	27.00%	Gross Margin	5.10%	52W Low	690.91%	ATR	0.55
Employees	67	Current Ratio	5.20	Sales Q/Q	-4.20%	Oper. Margin	-	RSI (14)	53.35	Volatility	10.96% 14.67%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.79	Prev Close	4.46
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 BMO	Payout	-	Avg Volume	4.99M	Price	4.35
Recom	-	SMA20	2.21%	SMA50	23.95%	SMA200	112.90%	Volume	291,454	Change	-2.47%

Oct-16-17

Reiterated

Chardan Capital Markets

Buy

$3.50 → $11.50

Aug-11-16

Reiterated

Chardan Capital Markets

Buy

$4.50 → $3.50

May-07-21 10:31AM	22nd Century Group (XXII) Q1 2021 Earnings Call Transcript Motley Fool
May-06-21 10:45AM	22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:00AM	22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021 GlobeNewswire
May-05-21 10:06AM	22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production GlobeNewswire -6.93%
May-04-21 09:20AM	22nd Century Group and KeyGene Extend and Expand Plant Research Partnership GlobeNewswire
Apr-30-21 11:05AM	22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles Still on the Table GlobeNewswire
06:40AM	An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring Motley Fool
Apr-29-21 06:50AM	Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities GlobeNewswire -15.66%
Apr-26-21 10:06AM	22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies GlobeNewswire
Apr-22-21 10:35AM	22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results GlobeNewswire
Apr-21-21 10:35AM	22nd Century Group Issues Annual Letter to Shareholders GlobeNewswire +6.95%
Apr-20-21 04:00PM	22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S. GlobeNewswire +5.35%
Apr-15-21 05:56PM	22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan GlobeNewswire
Apr-08-21 10:06AM	22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee GlobeNewswire +9.47%
Apr-06-21 07:12AM	3 Best Emerging Marijuana Stocks to Buy in April Motley Fool
Apr-01-21 10:06AM	Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century GlobeNewswire +5.78%
Mar-23-21 09:30AM	22nd Century Group (NYSEMKT:XXII) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -8.26%
Mar-19-21 01:00PM	Becerra Confirmation Boosts 22nd Centurys Position to Disrupt Tobacco Industry GlobeNewswire +5.61%
08:30AM	Do Options Traders Know Something About 22nd Century (XXII) Stock We Don't? Zacks
Mar-12-21 01:55PM	Why 22nd Century Group Stock Just Lit Up Motley Fool +12.96%
10:00AM	22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants GlobeNewswire
Mar-11-21 06:30PM	22nd Century Group (XXII) Q4 2020 Earnings Call Transcript Motley Fool +21.62%
07:00AM	22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020 GlobeNewswire
Mar-05-21 09:15AM	22nd Century Group to Participate in Investor Conferences in March 2021 GlobeNewswire +10.09%
Mar-04-21 12:30PM	Will 22nd Century Group (XXII) Report Negative Earnings Next Week? What You Should Know Zacks -11.74%
09:15AM	22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants GlobeNewswire
Mar-03-21 09:00AM	22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property GlobeNewswire -17.94%
Feb-25-21 07:30AM	22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results GlobeNewswire -14.75%
Feb-24-21 10:00AM	22nd Century Group Provides Business Update Letter from CEO GlobeNewswire
Feb-10-21 10:00AM	22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits GlobeNewswire +7.43%
Jan-28-21 10:00AM	22nd Century Group to Relocate Headquarters to Buffalos Thriving Larkinville District GlobeNewswire
Jan-26-21 12:00PM	The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in Cigarettes GlobeNewswire
Jan-19-21 07:30AM	Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group GlobeNewswire -5.40%
Jan-12-21 11:00PM	22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Companys Reduced Nicotine Content Cigarettes GlobeNewswire
Jan-11-21 12:00PM	22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Companys Reduced Nicotine Content Cigarettes GlobeNewswire
Dec-23-20 04:49AM	Did Business Growth Power 22nd Century Group's (NYSEMKT:XXII) Share Price Gain of 116%? Simply Wall St.
Dec-17-20 10:10AM	22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids GlobeNewswire
Dec-15-20 08:54AM	Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock? Zacks +5.53%
Dec-14-20 08:49AM	Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock? Zacks -7.48%
Dec-08-20 10:00AM	22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research GlobeNewswire +20.38%
Dec-04-20 10:00AM	22nd Century Group to Present at 13th Annual LD Micro Main Event Conference GlobeNewswire
Nov-29-20 08:37PM	Is 22nd Century Group, Inc (XXII) A Good Stock To Buy? Insider Monkey
Nov-24-20 11:00AM	22nd Centurys Vice President of Regulatory Science Publishes Important Public Policy Article GlobeNewswire
Nov-18-20 10:00AM	22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference GlobeNewswire +14.29%
Nov-16-20 09:45AM	22nd Century Group to Present at the Virtual Fall Investor Summit on November 17 GlobeNewswire +14.13%
Nov-12-20 08:36AM	Implied Volatility Surging for 22nd Century (XXII) Stock Options Zacks -5.59%
Nov-05-20 10:05AM	22nd Century Group (XXII) Reports Q3 Loss, Tops Revenue Estimates Zacks +16.94%
07:00AM	22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020 GlobeNewswire
Oct-29-20 12:35PM	22nd Century Group (XXII) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-22-20 10:00AM	22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A GlobeNewswire
Oct-19-20 10:00AM	22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institutes Tobacco and Nicotine Products Regulation and Policy Conference GlobeNewswire
Oct-15-20 08:58AM	22nd Century (XXII) in Focus: Stock Moves 9.9% Higher Zacks +7.07%
Oct-14-20 01:00PM	22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants GlobeNewswire +9.99%
Sep-24-20 04:05PM	22nd Century Group Provides Strategy Update Letter from CEO GlobeNewswire
Sep-23-20 12:26PM	Health Check: How Prudently Does 22nd Century Group (NYSEMKT:XXII) Use Debt? Simply Wall St.
Sep-17-20 04:05PM	22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors GlobeNewswire
Aug-31-20 06:05PM	LD Micro: 360 Companies Set to Present this Week ACCESSWIRE -7.10%
Aug-27-20 11:30AM	22nd Century Group to Present at the LD Micro 500 Virtual Conference GlobeNewswire
Aug-06-20 07:00AM	22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020 GlobeNewswire
Jul-09-20 07:00AM	22nd Century Group to Host Webcast of 2020 Second Quarter Results GlobeNewswire
Jul-01-20 10:59AM	Insider Buys 22nd Century Group's Stock Benzinga
Jun-08-20 09:03AM	Trade Alert: The Independent Chairman Of 22nd Century Group, Inc. (NYSEMKT:XXII), Nora Sullivan, Has Just Spent US$83k Buying 174% More Shares Simply Wall St. +21.39%
Jun-03-20 06:45AM	22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer GlobeNewswire
May-24-20 10:34PM	Edited Transcript of XXII earnings conference call or presentation 7-May-20 12:00pm GMT Thomson Reuters StreetEvents
May-22-20 10:27AM	Read This Before Selling 22nd Century Group, Inc. (NYSEMKT:XXII) Shares Simply Wall St. +6.94%
May-07-20 07:00AM	22nd Century Group Reports First Quarter 2020 Financial Results Business Wire -6.26%
Apr-30-20 02:00PM	22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials Business Wire
Apr-28-20 06:50AM	22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020 GlobeNewswire -7.17%
Apr-17-20 12:15PM	FDA Announces Deadline to Submit Comments on 22nd Century Groups MRTP Application GlobeNewswire +7.22%
Apr-08-20 04:15PM	22nd Century Group to Hold Virtual Annual Meeting of Stockholders GlobeNewswire
Mar-23-20 09:08AM	Does The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Price Fall With The Market? Simply Wall St.
Mar-12-20 06:50AM	22nd Century Group, Inc. Files 2019 Annual Report Business Wire -8.40%
Mar-11-20 04:15PM	22nd Century Announces Important New Achievements with KeyGene GlobeNewswire -6.54%
Mar-10-20 04:15PM	22nd Century Group Adds to Leadership Team GlobeNewswire +5.45%
Mar-04-20 01:04PM	CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking GlobeNewswire +8.62%
06:50AM	Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use GlobeNewswire
Feb-18-20 07:00AM	FDA Scientific Advisory Committee Discusses 22nd Century Groups Reduced Nicotine Cigarettes Business Wire -8.04%
Feb-11-20 01:30PM	22nd Century Groups FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry Business Wire +10.99%
Jan-22-20 01:25PM	If You Had Bought 22nd Century Group (NYSEMKT:XXII) Stock A Year Ago, You'd Be Sitting On A 50% Loss, Today Simply Wall St.
Jan-13-20 06:45AM	22nd Century Group Appoints New Director and New Chairman GlobeNewswire
Dec-23-19 03:39PM	22nd Century Group to Present its Modified Risk Tobacco Product Application to FDAs Tobacco Products Scientific Advisory Committee GlobeNewswire
Dec-17-19 01:34PM	FDA Authorizes Marketing of 22nd Century Groups Proprietary Moonlight® and Moonlight® Menthol Cigarettes GlobeNewswire +28.48%
Dec-13-19 04:03PM	22nd Century Group Announces Management Changes GlobeNewswire +5.21%
Dec-05-19 01:06PM	22nd Century Enters CBD Space With $24M Investment In Panacea Benzinga
Dec-03-19 06:09PM	Shareholder Alert: Robbins LLP Reminds Investors 22nd Century Group, Inc. (XXII) Sued for Misleading Shareholders Business Wire
05:24PM	22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc. GlobeNewswire
Nov-27-19 12:09AM	Edited Transcript of XXII earnings conference call or presentation 8-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Nov-21-19 08:51AM	22nd Century Group Comments on Delay of Reduced Nicotine Rule for Cigarettes GlobeNewswire +42.86%
Nov-07-19 04:30PM	22nd Century Group Files 2019 Third Quarter Report Business Wire
Nov-04-19 04:06PM	22nd Century Group Announces Webcast to Provide Business Update GlobeNewswire
Oct-10-19 03:50PM	Does 22nd Century Group (NYSEMKT:XXII) Have A Healthy Balance Sheet? Simply Wall St.
Sep-12-19 07:28AM	Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses Zacks
Sep-06-19 07:51AM	3 Pot Stocks to Avoid Like the Plague in September Motley Fool
Sep-03-19 07:21AM	Only These 10 Pot Stocks Ended August Higher Motley Fool
Aug-31-19 07:30AM	3 Best Marijuana Stocks of August -- Are They Buys Now? Motley Fool
Aug-28-19 06:15PM	22nd Century Group Inc (XXII) President and CEO Clifford B Fleet Bought $190,000 of Shares GuruFocus.com +5.41%
Aug-26-19 05:40AM	Will 22nd Century Group Continue to Surge Higher? Zacks
Aug-23-19 10:02AM	22nd Century Group, Inc. (NYSEMKT:XXII): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Aug-16-19 03:27AM	Edited Transcript of XXII earnings conference call or presentation 8-Aug-19 8:00pm GMT Thomson Reuters StreetEvents
Aug-09-19 07:03PM	22nd Century Group Inc (XXII) Q2 2019 Earnings Call Transcript Motley Fool +17.07%

22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MISH JAMES A	Chief Executive Officer	Mar 31	Buy	3.23	15,000	48,450	715,000	Mar 31 04:37 PM
SANDERS RICHARD M.	Director	Mar 17	Sale	2.72	47,227	128,457	314,972	Mar 19 04:07 PM
O'BRIEN ROGER D	Director	Mar 16	Buy	2.86	52,400	149,864	179,223	Mar 17 04:31 PM
SULLIVAN NORA B	Director	Feb 24	Option Exercise	0.95	138,376	131,457	446,899	Feb 26 04:25 PM
SANDERS RICHARD M.	Director	Feb 24	Option Exercise	0.95	138,376	131,457	362,199	Feb 26 04:14 PM
MISH JAMES A	Chief Executive Officer	Nov 17	Buy	0.93	100,000	92,800	250,000	Nov 17 02:32 PM
SULLIVAN NORA B	Director	Jun 29	Buy	0.78	22,000	17,160	308,523	Jun 30 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience